Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome

Radiotherapy and Oncology

Volumn 61, Issue 3, 2001, Pages 247-256

  Erkal, Haldun Ş ^a,b   Serin, Meltem ^a,c   Çakmak, Ahmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Carcinoma; Chemotherapy; Nasopharynx; Radiotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; SCHOOL CHILD; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TURKEY;

EID: 0035204898     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00448-0     Document Type: Article

References (47)

1. Nasopharyngeal cancer
2. Chemotherapy in advanced nasopharyngeal cancer
3. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma. A Radiation Therapy Oncology Group study
4. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III randomized intergroup study 0099
5. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy
6. Carcinoma of the nasopharynx. Results of radiation treatment and some prognostic factors
7. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma
8. The role of chemotherapy in the management of nasopharyngeal carcinoma
9. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
10. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma
11. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
12. Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx. Preliminary corroboration of the Intergroup experience
13. Regression models and life tables
14. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
15. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma
16. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Results of a matched cohort study
17. An epidemiological and clinical study of nasopharyngeal carcinoma
18. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma
19. Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy
20. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma. A positive effect on progression-free survival
21. Nonparametric estimation from incomplete observations
22. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985. Overall survival and patterns of failure
23. Nasopharyngeal carcinoma. Local control by megavoltage irradiation
24. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx
25. Evaluation of survival data and two new rank order statistics arising in its consideration
26. Reporting results of cancer treatment
27. Estimates of the worldwide incidence of twenty-five major cancers in 1990
28. Carcinoma of the nasopharynx. Factors affecting prognosis
29. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
30. Carcinoma of the nasopharynx treated by radiotherapy alone. Determinants of local and regional control
31. Nasopharyngeal carcinoma in childhood and adolescence
32. Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas
33. Prognostic factors of nasopharyngeal carcinoma. A review of 759 patients
34. Nasopharyngeal carcinoma in young patients
35. Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics
36. Combined treatment in carcinoma of the nasopharynx
37. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. The University of California-San Francisco experience
38. Prognostic factors of nasopharyngeal carcinoma. A multivariate analysis
39. Sequential chemotherapy and radiation for nasopharyngeal cancer. Absence of long-term benefit despite a high rate of tumor response to chemotherapy
40. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
41. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma. The existence of a dose-tumor-control relationship above conventional tumoricidal dose
42. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
43. Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma